Portfolio Companies
Our portfolio companies will be well-positioned to become leaders within the life sciences sectors. We invests in core technologies that can be foundations for building successful, profitable businesses over the long term.
The EMBL environment holds a reservoir of unique opportunities suitable for venture capital financing. The close relationship and proximity of our Fund to the EMBL and it's co-operation partners guarantees a positive impulse for the establishment of new start-up companies. We invite you to learn more about EMBL spin-out companies by using the links below.
- Savira Pharmaceuticals GmbH
- biobyte solutions GmbH
- ELARA Pharmaceuticals GmbH
- PEPperPRINT GmbH
- ENVIVO Pharmaceuticals Inc.
- Gene Bridges GmbH
- Cellzome AG
- Anadys Pharmaceutical Inc.
- Cenix BioScience GmbH
- Lion Bioscience AG